184 related articles for article (PubMed ID: 36350562)
21. Reduced podocin expression in minimal change disease and focal segmental glomerulosclerosis is related to the level of proteinuria.
Agrawal V; Prasad N; Jain M; Pandey R
Clin Exp Nephrol; 2013 Dec; 17(6):811-8. PubMed ID: 23377573
[TBL] [Abstract][Full Text] [Related]
22. Assessment of urinary angiotensinogen as a marker of podocyte injury in proteinuric nephropathies.
Eriguchi M; Yotsueda R; Torisu K; Kawai Y; Hasegawa S; Tanaka S; Noguchi H; Masutani K; Kitazono T; Tsuruya K
Am J Physiol Renal Physiol; 2016 Feb; 310(4):F322-33. PubMed ID: 26632605
[TBL] [Abstract][Full Text] [Related]
23. Comparison of Glomerular Transcriptome Profiles of Adult-Onset Steroid Sensitive Focal Segmental Glomerulosclerosis and Minimal Change Disease.
Tong J; Xie J; Ren H; Liu J; Zhang W; Wei C; Xu J; Zhang W; Li X; Wang W; Lv D; He JC; Chen N
PLoS One; 2015; 10(11):e0140453. PubMed ID: 26536600
[TBL] [Abstract][Full Text] [Related]
24. Immunoglobulin G/albumin staining in tubular protein reabsorption droplets in minimal change disease and focal segmental glomerulosclerosis.
Bu L; Mirocha J; Haas M
Nephrol Dial Transplant; 2021 May; 36(6):1016-1022. PubMed ID: 32191308
[TBL] [Abstract][Full Text] [Related]
25. Glomerular endothelial cells and podocytes can express CD80 in patients with minimal change disease during relapse.
Cara-Fuentes G; Venkatareddy M; Verma R; Segarra A; Cleuren AC; Martínez-Ramos A; Johnson RJ; Garg P
Pediatr Nephrol; 2020 Oct; 35(10):1887-1896. PubMed ID: 32399663
[TBL] [Abstract][Full Text] [Related]
26. The urinary podocyte as a marker for the differential diagnosis of idiopathic focal glomerulosclerosis and minimal-change nephrotic syndrome.
Nakamura T; Ushiyama C; Suzuki S; Hara M; Shimada N; Ebihara I; Koide H
Am J Nephrol; 2000; 20(3):175-9. PubMed ID: 10878397
[TBL] [Abstract][Full Text] [Related]
27. [Nephrotic syndrome in minimal change disease (kidney), focal segmental glomerulosclerosis, and focal mesangioproliferative glomerulonephritis].
Voznesenskaia TS; Sergeeva TV
Ter Arkh; 2002; 74(6):31-3. PubMed ID: 12136479
[TBL] [Abstract][Full Text] [Related]
28. Detection of activated parietal epithelial cells on the glomerular tuft distinguishes early focal segmental glomerulosclerosis from minimal change disease.
Smeets B; Stucker F; Wetzels J; Brocheriou I; Ronco P; Gröne HJ; D'Agati V; Fogo AB; van Kuppevelt TH; Fischer HP; Boor P; Floege J; Ostendorf T; Moeller MJ
Am J Pathol; 2014 Dec; 184(12):3239-48. PubMed ID: 25307344
[TBL] [Abstract][Full Text] [Related]
29. Podocin and uPAR are good biomarkers in cases of Focal and segmental glomerulosclerosis in pediatric renal biopsies.
Pereira LHM; da Silva CA; Monteiro MLGDR; Araújo LS; Rocha LP; Reis MBDR; Ramalho FS; Corrêa RRM; Silva MV; Reis MA; Machado JR
PLoS One; 2019; 14(6):e0217569. PubMed ID: 31188898
[TBL] [Abstract][Full Text] [Related]
30. Glomerular tip lesion: a distinct entity within the minimal change disease/focal segmental glomerulosclerosis spectrum.
Stokes MB; Markowitz GS; Lin J; Valeri AM; D'Agati VD
Kidney Int; 2004 May; 65(5):1690-702. PubMed ID: 15086908
[TBL] [Abstract][Full Text] [Related]
31. The parietal epithelial cell: a key player in the pathogenesis of focal segmental glomerulosclerosis in Thy-1.1 transgenic mice.
Smeets B; Te Loeke NA; Dijkman HB; Steenbergen ML; Lensen JF; Begieneman MP; van Kuppevelt TH; Wetzels JF; Steenbergen EJ
J Am Soc Nephrol; 2004 Apr; 15(4):928-39. PubMed ID: 15034095
[TBL] [Abstract][Full Text] [Related]
32. Glomerular malondialdehyde levels in patients with focal and segmental glomerulosclerosis and minimal change disease.
Nezhad ST; Momeni B; Basiratnia M
Saudi J Kidney Dis Transpl; 2010 Sep; 21(5):886-91. PubMed ID: 20814126
[TBL] [Abstract][Full Text] [Related]
33. Epithelial cell foot process effacement in podocytes in focal and segmental glomerulosclerosis: a quantitative analysis.
Kfoury H
Ultrastruct Pathol; 2014 Oct; 38(5):303-8. PubMed ID: 24956069
[TBL] [Abstract][Full Text] [Related]
34. Urinary low-molecular-weight protein excretion in pediatric idiopathic nephrotic syndrome.
Chehade H; Parvex P; Poncet A; Werner D; Mosig D; Cachat F; Girardin E
Pediatr Nephrol; 2013 Dec; 28(12):2299-306. PubMed ID: 23949592
[TBL] [Abstract][Full Text] [Related]
35. CD80 and suPAR in patients with minimal change disease and focal segmental glomerulosclerosis: diagnostic and pathogenic significance.
Cara-Fuentes G; Wei C; Segarra A; Ishimoto T; Rivard C; Johnson RJ; Reiser J; Garin EH
Pediatr Nephrol; 2014 Aug; 29(8):1363-71. PubMed ID: 24263531
[TBL] [Abstract][Full Text] [Related]
36. Potential Urine Proteomic Biomarkers for Focal Segmental Glomerulosclerosis and Minimal Change Disease.
Chebotareva NV; Vinogradov A; Brzhozovskiy AG; Kashirina DN; Indeykina MI; Bugrova AE; Lebedeva M; Moiseev S; Nikolaev EN; Kononikhin AS
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293475
[TBL] [Abstract][Full Text] [Related]
37. Reduced INF2 expression in nephrotic syndrome is possibly related to clinical severity of steroid resistance in children.
Tamura H; Nakazato H; Kuraoka S; Yoneda K; Takahashi W; Endo F
Nephrology (Carlton); 2016 Jun; 21(6):467-75. PubMed ID: 26383224
[TBL] [Abstract][Full Text] [Related]
38. Focal segmental glomerulosclerosis: towards a better understanding for the practicing nephrologist.
Sethi S; Glassock RJ; Fervenza FC
Nephrol Dial Transplant; 2015 Mar; 30(3):375-84. PubMed ID: 24589721
[TBL] [Abstract][Full Text] [Related]
39. Cell-cycle regulatory proteins in the podocyte in collapsing glomerulopathy in children.
Srivastava T; Garola RE; Singh HK
Kidney Int; 2006 Aug; 70(3):529-35. PubMed ID: 16775597
[TBL] [Abstract][Full Text] [Related]
40. [Evaluation of the podocytes in urine in the nephrotic syndrome in childhood].
Spadło A; Wyka K; Kowalewska-Pietrzak M; Bodalski J
Pol Merkur Lekarski; 2007 Apr; 22(130):254-7. PubMed ID: 17684921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
